From: Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs
Fibrosis staging
Before treatment
12 weeks after treatment
MH
p
No.
%
F0/1
14
35.0
23
57.5
32.0*
<0.001*
F2
11
27.5
8
20.0
F3
3
7.5
F4
7
17.5
6
15.0